Yubo International Biotech Limited (YBGJ)

Market Cap	1.43M -94.4%
Revenue (ttm)	12.35K +256.0%
Net Income	-916.23K
EPS	-0.01
Shares Out	170.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0084
Previous Close	0.0084
Day's Range	0.0084 - 0.0084
52-Week Range	0.0079 - 0.1776
Beta	0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About YBGJ

Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. It also provides light application products, including respiratory atomization products; cell basidiomycetes compound dr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• CEO: Yang Wang
• Employees: 14
• Stock Exchange: OTCMKTS
• Ticker Symbol: YBGJ

Financial Performance

In 2025, YBGJ's revenue was $12,353, an increase of 255.99% compared to the previous year's $3,470. Losses were -$1.08 million, -39.21% less than in 2024.